Skip 
Navigation Link
Medical Disorders
Resources
Basic InformationLookupsLatest News
Family History Questionnaire Ups Genetic Counseling for CRCBlood Test Can Detect GLUT1 Deficiency SyndromeWallpaper May Breed Toxins: StudyFish Eaters Report Less Rheumatoid Arthritis PainGuided Exercise May Help Chronic Fatigue Patients: Study2006 to 2013 Saw Increase in ER Use for Herpes ZosterNearly 60 Percent With Conjunctivitis Fill Antibiotic RxTissue Testing Can Spot Zika at Birth: CDCGuidelines Address Peri-Op Care in Rheumatic DiseaseZika-Bearing Mosquitoes More Widespread in U.S. Than ExpectedMarital Status Among Factors Tied to Gout Rx AdherenceMany Chronic Illnesses Linked to Suicide RiskVaccine Curbs High Cholesterol in MiceStudy Hints at Link Between Some Statins, Parkinson's RiskHydrotherapy Plus Conventional Drugs Beneficial in RAChronic Lyme Disease Treatments Tied to Serious Adverse EffectsOlder Age Needn't Be a Barrier to Herniated Disc SurgeryNon-Opioid Drug More Effective for Migraines: StudyHealth Tip: Managing Arthritis FatigueCertain Criteria May Be Better Than Others in RA Assessment20 Percent of Hospital Patients Have Side Effects From Abx RxRecreational Activity-Linked Facial Fractures Up in SeniorsUnusual Measles Outbreak Described in Ontario in Early 2015Seniors Get Good Results From Herniated Disc Surgery'Good' Donor Bacteria Can Last Long Term in Stool Transplant PatientsNovel Retinal Lesion Seen in Some Ebola SurvivorsHealth Tip: Recognizing Summer Allergy SymptomsAre You at Risk for Metabolic Syndrome?Antiplatelet Bleeding Risk Higher Than Expected for Older PatientsVideo Call May Be as Good as Doctor Visit for HeadacheCould Prefab Blood Vessels Revolutionize Root Canals?A Sufferer's Guide to Easin' Sneezin' SeasonHospitals Get Good News About Fighting Staph InfectionsCases of Legionnaires' Disease Reported in NYC, Las VegasOlive Oil, Ibuprofen May Have Synergistic EffectsObesity Prevalence Has Doubled in More Than 70 CountriesSeveral New Medications in the Pipeline to Prevent MigraineReview: Depression Screening As Inpatient Important, FeasibleVitamin B6 Linked to Increased Risk of Hip Fracture2 Billion Worldwide Are Obese or OverweightPatient's Education Level May Be Key to Heart RiskMeds Rooted in Ancient China May Help Heart: ReviewBats Harbor Viruses That Could Cause Outbreaks in HumansExperimental Zika Vaccine Protects Mice Against Virus: StudyGlobal Climate Change Could Cause Rise in Airway IrritationEqual Wound Complications for Staples, Suture in Obese WomenDepression Can Slow Hospital Patients' Recovery: StudyEven Your Bones Can Get Fat, Mouse Study SuggestsNew Drugs Show Promise as First to Prevent Migraine1 in 7 Americans Has Kidney Disease: CDC
Questions and AnswersLinksBook Reviews
Related Topics

Hospitals Get Good News About Fighting Staph Infections

HealthDay News
by -- Robert Preidt
Updated: Jun 14th 2017

new article illustration

TUESDAY, June 13, 2017 (HealthDay News) -- Staphylococcus aureus infections among U.S. hospital patients have been less resistant to key antibiotics in recent years, a new study finds.

Between 2009 and 2015, researchers tested antibiotic resistance in more than 19,000 S. aureus samples from 42 medical centers nationwide.

"Results showed that S. aureus' rates of resistance to certain antibiotics decreased over time, which isn't often seen," study co-author Dr. Helio Sader said in an American Society for Microbiology news release. Sader is senior director of microbiology and surveillance at JMI Laboratories in North Liberty, Iowa.

Rates of S. aureus resistance to the antibiotic oxacillin (Bactocill) fell from 47.2 percent in 2009 to 43.6 percent in 2015 to 42.2 percent in 2016.

S. aureus resistance to other antibiotics, such as levofloxacin (Levaquin), clindamycin (Cleocin) and erythromycin, also decreased. Resistance to ceftaroline (Teflaro), trimethoprim-sulfanethoxazole (Bactrim), and tetracycline was stable, the researchers said.

The study also found that the antibiotic ceftaroline remained very effective against methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus during the study period.

Also, S. aureus resistance to daptomycin (Cubicin), linezolid (Zyvox), vancomycin (Vancocin) and tigecycline (Tygacil) stayed extremely rare with no sign of increasing, the study found.

The findings were presented recently at the American Society for Microbiology annual meeting, in New Orleans. Research presented at meetings is considered preliminary until published in a peer-reviewed journal.

More information

The U.S. Centers for Disease Control and Prevention has more on antibiotic resistance.